New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:15 EDTWAT, XRX, ST, NWSA, BBY, SNY, BW, SPLS, O, NTAP, ASML, PG, HAL, SNE, NSC, FBOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ASML (ASML) upgraded to Buy from Neutral at Citigroup... Best Buy (BBY) upgraded to Buy from Hold at BB&T... Facebook (FB) upgraded to Outperform from Market Perform at Raymond James... NetApp (NTAP) upgraded to Overweight from Equal Weight at Barclays... News Corp. (NWSA) upgraded to Overweight from Equal Weight at Morgan Stanley... Norfolk Southern (NSC) upgraded to Buy from Hold at Jefferies... Realty Income (O) upgraded to Outperform from Market Perform at Wells Fargo... Sensata (ST) upgraded to Overweight from Equal Weight at Barclays... Sony (SNE) upgraded to Buy from Neutral at Citigroup... Staples (SPLS) upgraded to Neutral from Sell at Goldman... Xerox (XRX) upgraded to Outperform from Market Perform at BMO Capital... BorgWarner (BW) upgraded to Buy from Hold at KeyBanc... Halliburton (HAL) upgraded to Buy from Hold at MLV Equity... Waters (WAT) upgraded to Buy from Hold at WallachBeth... Procter & Gamble (PG) upgraded to Buy from Neutral at B. Riley Caris... Sanofi (SNY) upgraded to Neutral from Conviction Sell at Goldman.
News For ASML;BBY;FB;NTAP;NWSA;NSC;O;ST;SNE;SPLS;XRX;HAL;BW;WAT;PG;SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
May 15, 2015
08:46 EDTFBMobile operators ad blocking plan sets up fight with Google, FT reports
Subscribe for More Information
08:09 EDTSPLSStaples June volatility elevated into Q1 and outlook
Subscribe for More Information
07:38 EDTPGP&G fighting lawsuits over laundry-pod poisonings, WSJ reports
Procter & Gamble (PG), which has a commanding spot in the laundry-pod market and has put the products at the center of its laundry strategy, is defending itself against several lawsuits alleging injuries from the products, reported The Wall Street Journal. The Journal noted it reviewed data showing that at least seven people, including four last year and one earlier this year, have died after biting into laundry-pods. A P&G spokesman said there are indications that the rate of accidents relative to the number of pods sold is declining since 2012, when the products were first introduced in the U.S. Reference Link
07:09 EDTHALHayman Capital gives quarterly update on stakes
Subscribe for More Information
06:44 EDTNSCEnvironmentalists file lawsuit over oil train safety rules, NY Times says
Subscribe for More Information
05:52 EDTSPLSStocks with implied volatility above IV index mean; KORS SPLS
Subscribe for More Information
May 14, 2015
16:00 EDTFBOptions Update; May 14, 2015
Subscribe for More Information
13:12 EDTNSCNorfolk Southern names Alan Shaw Chief Marketing Officer
Subscribe for More Information
11:29 EDTNSCNorfolk Southern CEO says 'confident' in company's long-term strengths
Addressing his last annual meeting as Norfolk Southern's CEO, Wick Moorman told shareholders that "we see continuing strength in the overall economy as well as opportunities in many of the markets we serve," and, "We are confident in our company's long-term strengths and prospects for continued success." President Jim Squires becomes CEO June 1, and Moorman will remain as executive chairman of the board. Moorman reviewed company highlights of 2014, which included "earning record income, revenues, and earnings per share while establishing its best-ever operating ratio, a key indicator of operating performance." These accomplishments were especially significant, Moorman said, considering 2014's extreme winter weather and traffic surges that exceeded expectations, which created service challenges. He delivered an upbeat message to customers and stockholders. "We expect to reach the strong velocity and service levels we saw in 2012 and 2013 by the second half of this year," Moorman said. "As we restore our network's velocity and efficiency, we will be able to secure additional business at rates that will drive positive returns for our shareholders."
09:34 EDTFBActive equity options trading on open
Subscribe for More Information
09:19 EDTNSCKansas City Southern drops after withdrawing 2015 revenue, volume guidance
Subscribe for More Information
06:24 EDTNTAPCiti expects 'lukewarm' Q4 results from NetApp
Citigroup expects NetApp to report "lukewarm" Q4 results on Wednesday amid "soft" underlying storage demand and "modest" currency pressure. The company's sales and earnings are likely to be in-line to a slight miss relative to consensus, Citi believes. The firm says that while the stock's valuation "looks interesting," it keeps a Neutral rating on the name with a $39 price target.
May 13, 2015
16:06 EDTFBOptions Update; May 13, 2015
iPath S&P 500 VIX Short-Term Futures down 38c to 20.67. Option volume leaders: AAPL CSCO NTI FB CSX BABA EIX BAC DD WMB TSLA JCP QCOM DAL
10:46 EDTNSCRail estimates lowered at Wolfe Research
Subscribe for More Information
08:21 EDTFBFormer FCC chairman hired by Facebook to manage access efforts, Bloomberg says
Kevin Martin, the former chairman of the FCC who has been consulting for Facebook the past two years, is joining on a permanent basis as the company's VP for mobile and global access policy, reported Bloomberg. Facebook also announced that Chief Privacy Officer Erin Egan will start serving a dual role as VP of U.S. Public Policy, the report added. Reference Link
07:31 EDTSNYHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
07:05 EDTSNYSanofi exercises option on therapeutic program with Selecta Biosciences
Selecta Biosciences., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies, today announced that, under the terms of an existing strategic global collaboration, Sanofi has exercised its option to an exclusive license to develop an immunotherapy for the treatment of celiac disease. Under the terms of the collaboration, Selecta is eligible to receive research support and several pre-clinical, clinical, regulatory and sales milestones totaling up to $300 million for this new program in celiac disease. Additionally, Selecta is also entitled to up to double digit tiered royalties as percentage of product net sales for any commercialized immunotherapy resulting from these efforts with Sanofi. November 2012, Selecta announced that they had formed a strategic global collaboration to discover highly targeted, antigen-specific immunotherapies for life threatening allergies. Under the agreement, Sanofi obtained a first exclusive license to develop an immunotherapy designed to abate acute immune responses against a life threatening food allergen and an option to develop two additional candidate immunotherapies for allergies and celiac disease. With the exercise of this option by Sanofi, Selecta and Sanofi now have two initiatives actively advancing immune tolerance treatments under the terms of the 2012 agreement. In October 2014, Selecta and JDRF announced another collaboration with Sanofi to research novel antigen-specific immune therapies for Type 1 Diabetes.
06:35 EDTBBYBest Buy May volatility elevated into Q1 and outlook
Best Buy May weekly call option implied volatility is at 54, June is at 34, September is at 33; compared to its 90-day average of 32 according to Track Data, suggesting large near term price movement into the expected release of Q1 earnings on May 21.
06:22 EDTFBFacebook introduces Instant Articles, says working with nine launch partners
Subscribe for More Information
05:25 EDTSPLSStaples announces partnerships with Bidvest Waltons, Dacris
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use